Total
0
Shares
XORTX Therapeutics - CEO, Allen Davidoff.
CEO, Allen Davidoff.
Source: Richmond Club.
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • XORTX (XRX) begins trading today on the Nasdaq Capital Market in conjunction with a US$12 million public offering
  • The company’s Nasdaq shares are listed under the symbol XRTX
  • It will offer 2,906,000 units at a price of US$4.13 per unit with Alliance Global Partners acting as sole bookrunner
  • The offering is expected to close on or about October 15, 2021
  • XORTX Therapeutics is a pharmaceutical company focused on products to treat kidney disease, COVID-19 and type 2 diabetic nephropathy
  • XORTX (XRX) is down by 30.13 per cent and is currently trading at $4.15 per share

XORTX (XRX) begins trading today on the Nasdaq Capital Market in conjunction with a US$12 million public offering.

The company’s Nasdaq shares are listed under the symbol XRTX.

The offering comprises 2,906,000 units at a price of US$4.13 per unit with Alliance Global Partners acting as sole bookrunner.

Each unit consists of one common share, no par value and one warrant to purchase one common share.

Each warrant has an initial exercise price of US$4.77 per share, will be immediately exercisable and will have a term of approximately five years.

The common shares and warrants are immediately separable upon issuance.

The underwriters have a 45-day option to purchase up to an additional 435,900 common shares and/or warrants to purchase up to an additional 435,900 common shares at the offering price.

The offering is expected to close on or about October 15, 2021.

XORTX Therapeutics is a pharmaceutical company focused on products to treat kidney disease, COVID-19 and type 2 diabetic nephropathy.

XORTX (XRX) is down by 30.13 per cent and is currently trading at $4.15 per share as of 10:52 am ET.

More From The Market Herald

" Andlauer Healthcare Group (TSX:AND) completes $169M bought deal offering

Andlauer Healthcare Group Inc. (AND) and Andlauer Management Group Inc. completed a bought deal offering of 3.5 million subordinate voting shares (SVSs).

" Avricore (TSXV:AVCR) expands HealthTab to select Shoppers Drug Mart locations in BC

Avricore Health (AVCR) has expanded its patient testing with the HealthTab platform in select Shoppers Drug Mart pharmacies in BC.

" Sego Resources (TSXV:SGZ) announces a non-brokered private placement

Sego Resources (SGZ) has announced a non-brokered private placement for proceeds of up to $405,000.

" Clearmind (CSE:CMND) signs development and supply agreement with Aragen Life Sciences

Clearmind Medicine (CMND) will work with Aragen Life Sciences to produce its innovative molecule, 5-Methoxy-2-aminoindane (MEAI).